Compare FBIOP & GFUZW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FBIOP | GFUZW |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2011 | 2025 |
| Metric | FBIOP | GFUZW |
|---|---|---|
| Price | $18.52 | $1.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 9.0K | ★ 35.9K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.40 | N/A |
| EPS | ★ 2.86 | N/A |
| Revenue | ★ $63,262,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.52 | ★ N/A |
| Revenue Growth | ★ 9.69 | N/A |
| 52 Week Low | $6.27 | $1.26 |
| 52 Week High | $21.43 | $2.30 |
| Indicator | FBIOP | GFUZW |
|---|---|---|
| Relative Strength Index (RSI) | 44.76 | 52.96 |
| Support Level | $17.95 | $1.26 |
| Resistance Level | $18.91 | $2.12 |
| Average True Range (ATR) | 0.22 | 0.14 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 60.98 | 81.08 |
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
General Fusion Group Ltd is focused on developing fusion energy technology based on Magnetized Target Fusion (MTF), which combines magnetic confinement and mechanical compression to achieve fusion conditions. It operates a large-scale demonstration system, Lawson Machine 26 (LM26), intended to validate elements of its technology and support the development of commercial fusion power plants for electricity generation.